#Sovaldi Mylan Receives WHO Prequalification for Sovaldi, Gilead Sciences Mylan Pharma Sovaldi Wholesale Price, Genuine #Sovaldi Tablets, Hepatitis C Drugs Wholesale #MedsDelta Call +91-9971646666
Mylan Pharmaceuticals Private Limited has launched Gilead Sciences’ Sovaldi (sofosbuvir 400mg tablets) in India. Sovaldi is indicated for the treatment of chronic hepatitis C infection, a blood-borne infectious disease, as a component of a combination antiviral treatment regimen. It is estimated that approximately 12 million people are chronically infected with hepatitis C in India.

Brand Name: Sovaldi
Content: Sofosbuvir
Manufacturer: Gilead Sciences Inc
Marketed by: Gilead Sciences Inc and Mylan Pharmaceuticals Pvt Ltd
Strength: 400 mg
Form: Tablets
Packing: Pack of 28 Tablets
QQ :3451266709@qq.com
Mobile : +91-9971646666
Skype: MedsDelta
WeChat : MedsDelta
WhatsApp : +91-9971646666
Viber : +91-9971646666